嘉元科技(688388.SH):擬3000萬元投資設立全資孫公司開展新業務
格隆匯7月24日丨嘉元科技(688388.SH)公佈,全資子公司嘉元科創公司擬投資設立“深圳嘉元新材料科技創新有限公司”,註冊資本3000萬元,嘉元科創公司持有新公司股權比例為100%。新公司依託嘉元科技現有先進銅箔生產技術,通過創新研發和技術轉化,以金屬新材料生產加工為突破,形成研發、成果轉化與項目孵化、產業服務一體化的經營格局。
新公司發展初期,為加快運作效率,擬以金基材料核心產品——新型金箔為產品推向市場,在新能源、電子信息、航空航天、建築工程、裝修工程、文創工藝、出口市場等領域開展銷售,為新公司的良性發展奠定基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.